FDA Approved: ELREXFIO — Original Application (U.S. Pharmaceuticals)

View source ↗

Summary

FDA approved ELREXFIO (elranatamab-BCMM) via an Original Application for use in adults with multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• ELREXFIO (ELRANATAMAB-BCMM)

Snippet

ORIG AP for ELREXFIO (ELRANATAMAB-BCMM)